Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP17A1 | P05093 | 1/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.33 |
| ▸ | MDH1 | P40925 | 1/20 | 0.32 |
| ▸ | MDH2 | P40926 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14701762 | 0.88 | CYP19A1 (0.40) | CYP17A1CYP19A1ALDH1A1NPSR1 | |
| SCHEMBL14704021 | 0.88 | MDH1 (0.32) | MDH1MDH2 | |
| SCHEMBL776275 | 0.86 | CYP17A1 (0.36) | CYP17A1CYP19A1MDH1MDH2ALDH1A1 | |
| SCHEMBL14701771 | 0.85 | MDH1 (0.32) | CYP17A1CYP19A1MDH1MDH2ALDH1A1 | |
| SCHEMBL686291 | 0.82 | ALDH1A1 (0.36) | CYP17A1CYP19A1MDH1MDH2ALDH1A1 | |
| SCHEMBL25739907 | 0.82 | HSD11B1 (0.37) | CYP17A1CYP19A1MDH1MDH2ALDH1A1 | |
| SCHEMBL14701801 | 0.82 | MDH1 (0.35) | CYP17A1CYP19A1MDH1MDH2ALDH1A1 | |
| SCHEMBL12093466 | 0.81 | CYP17A1 (0.34) | CYP17A1CYP19A1MDH1MDH2ALDH1A1 | |
| SCHEMBL14704050 | 0.81 | MDH1 (0.32) | MDH1MDH2 | |
| SCHEMBL776067 | 0.80 | MDH1 (0.36) | CYP17A1CYP19A1MDH1MDH2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9051251-B2 | Salt, photoresist composition and method for producing photoresist pattern | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-06-09 | — | — | US | disclosed |
| US-20130040237-A1 | SALT, PHOTORESIST COMPOSITION AND METHOD FOR PRODUCING PHOTORESIST PATTERN | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130040237-A1 | SALT, PHOTORESIST COMPOSITION AND METHOD FOR PRODUCING PHOTORESIST PATTERN | F12, C1S, FRG1 | CYP17A1 2059/4885CYP19A1 2743/4885MDH1 4648/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.